CareDx (CDNA) Research & Development (2013 - 2026)

CareDx has disclosed Research & Development across 14 years of filings, most recently posting $33.4 million for Q2 2026.

• In Q2 2026, Research & Development rose 37.74% year-over-year to $33.4 million; the TTM figure through Jun 2026 stood at $119.2 million (up 34.81% YoY), while the FY2025 annual figure was $102.6 million, up 25.21% from the prior year.
• Research & Development came in at $33.4 million for Q2 2026 at CareDx, up from $30.4 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $33.4 million in Q2 2026 to a low of $19.0 million in Q3 2023.
• Average Research & Development over 5 years is $23.9 million, with a median of $23.1 million recorded in 2022.
• Year-over-year, Research & Development dropped 19.74% in 2023 and soared 44.9% in 2025.
• Over 5 years, Research & Development stood at $23.7 million in 2022, then declined by 13.5% to $20.5 million in 2023, then increased by 4.24% to $21.3 million in 2024, then soared by 44.9% to $30.9 million in 2025, then gained by 8.14% to $33.4 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $33.4 million in Q2 2026, $30.4 million in Q1 2026, and $30.9 million in Q4 2025.